PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study
ConclusionsThe serum level of PIVKA-II was significantly higher in children with hepatic tumors, especially those with malignant tumors. The combination of PIVKA-II with AFP further increased the diagnostic performance.Trial registrationClinical Trials, NCT03645655. Registered 20 August 2018,https://www.clinicaltrials.gov/ct2/show/NCT03645655.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Cancer & Oncology | Chemotherapy | Children | China Health | Hemangioendothelioma | Hepatoblastoma | Infectious Diseases | Study | Vitamin K | Vitamins